Immune evasion of tumor cells by phagocytosis disruption via CD47-mediated blockade turned out to have critical roles in cancer immunotherapy, CD47 representing an “immune checkpoint molecule” whose therapeutic modulation could unravel promising strategies for further clinical applications, and its expression level could be considered as a relevant prognostic marker in gliomas [106,108,113]. The gene discussed is CD47; the disease is cancer.